Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology Guideline
British Journal of Haematology · 2026-06 · 208 (6) · 1931-1938
DOI: 10.1111/bjh.70472 ↗Kurz gefasst
Leitlinie in der Zeitschrift British Journal of Haematology, online erschienen am 07.05.2026. Verfasst von Mamta Garg und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Hospitals Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Amyloidosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
AL amyloidosis is caused by a plasma cell clone that produces abnormal light chains that misfold and deposit as amyloid fibrils in tissues and thus affect organ function. The survival of patients with systemic amyloid light‐chain (AL) amyloidosis largely depends on the extent of end‐organ damage. Patients with early‐stage disease can expect approximately 80% survival at 5 years with contemporary treatment, compared to less than 30% for those with advanced disease. The aim of this guideline is to facilitate recognition and raise suspicion of amyloidosis. It is important to recognise that amyloidosis can present in any clinic, including general medicine/care of the elderly and general practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospitals Leicester, Leicester, UK.
- Northern Cancer Alliance NHS Foundation Trust, Manchester, UK.
- Leeds Institute of Clinical Trials Research, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK.
- The Clatterbridge Cancer Centre NHS Foundation Trust, Birkenhead, UK.
- National Amyloidosis Centre, Royal Free London NHS Foundation Trust, London, UK.
- Myeloma UK, Edinburgh, UK.
ORCID-Profile: Mamta Garg, Satarupa Choudhuri, Christopher Parrish, Y L Tracey Chan
Zitieren
APA
Garg, M., Choudhuri, S., Parrish, C., Hawkins, S., Lachmann, H., Clayton, L., Richardson, J., Chan, Y. L. T., & Wechalekar, A. (2026). Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology Guideline. British Journal of Haematology, 208(6), 1931-1938. https://doi.org/10.1111/bjh.70472
Vancouver
Garg M, Choudhuri S, Parrish C, Hawkins S, Lachmann H, Clayton L, et al. Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology Guideline. British Journal of Haematology. 2026;208(6):1931-1938. doi:10.1111/bjh.70472
BibTeX
@article{Garg2026,
author = {Garg, Mamta and Choudhuri, Satarupa and Parrish, Christopher and Hawkins, Stephen and Lachmann, Helen and Clayton, Louise and Richardson, Judith and Chan, Y L Tracey and Wechalekar, Ashutosh},
title = {Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology Guideline},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {6},
pages = {1931--1938},
doi = {10.1111/bjh.70472}
}
EUVIMED